肠道菌群与慢性肾脏病的研究进展
Research Progress of Intestinal Flora and Chronic Kidney Disease
DOI: 10.12677/ACM.2021.111049, PDF,    科研立项经费支持
作者: 薛 雯, 唐立红, 朱俊芳, 陈洁晶：中国人民解放军联勤保障部队第九二四医院检验科，广西代谢性疾病研究重点实验室，广西 桂林；刘永玲*：中国人民解放军联勤保障部队第九二四医院卫勤处，广西 桂林
关键词: 肠道菌群；慢性肾脏病；菌群失调；机体疾病；Gut Flora； Chronic Kidney Disease； Dysbacteriosis； Diseases of the Body
摘要: 慢性肾脏疾病(chronic kidney disease, CKD)近年来的发病率逐年升高，严重威胁着人类的健康和生命。其包括由各种因素引起的原发性、继发性肾脏疾病。肥胖、糖尿病、高血压、肾小球肾炎都可导致CKD，CKD已经成为全球性公共健康问题，其患病率和病死率高。本文针对肠道菌群对慢性肾脏病的影响进行综述，肠道菌群失调与CKD的发生关系密切，可为以肠道菌群为靶点的预防和治疗相关疾病提供强有力的理论基础。
Abstract: The incidence of chronic kidney disease (CKD) is increasing year by year in recent years, which threatens human health and life seriously. CKD includes primary and secondary renal diseases caused by various factors. Obesity, diabetes, high blood pressure, and glomerulonephritis can all lead to CKD, which has become a global public health problem with high morbidity and mortality. This article reviews the influence of Intestinal microflora on chronic kidney disease. The imbalance of intestinal microflora is closely related to CKD, which provides a strong theoretical basis for the prevention and treatment of diseases related to intestinal microflora.
文章引用：薛雯, 唐立红, 朱俊芳, 陈洁晶, 刘永玲. 肠道菌群与慢性肾脏病的研究进展[J]. 临床医学进展, 2021, 11(1): 345-349. https://doi.org/10.12677/ACM.2021.111049

参考文献

[1] Sender, R., Fuchs, S. and Milo, R. (2016) Are We Really Vastly Outnumbered Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell, 164, 337-340.
[Google Scholar] [CrossRef] [PubMed]
[2] 翟齐啸, 田丰伟, 王刚, 陈卫. 肠道微生物与人体健康的研究进展[J]. 食品科学, 2013, 34(15): 337.
[3] 龙晓蕾, 李梓民, 周月婵, 等. 低聚果糖口服液对人体肠道菌群的影响[J]. 应用预防医学, 2016, 22(3): 227-229.
[4] Ranganat Han, N., Ranganat Han, P., Friedman, E.A., et al. (2010) Pilot Study of Probiotic Dietary Supplementation for Promoting Healthy Kidney Function in Patients with Chronic Kidney Disease. Advances in Therapy, 27, 634-647.
[Google Scholar] [CrossRef] [PubMed]
[5] Andrade-Oliveira, V., Amano, M.T., Correacosta, M., et al. (2015) Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion. Journal of the American Society of Nephrology, 26, 1877-1888.
[Google Scholar] [CrossRef] 
[6] 中华人民共和国国家卫生和计划生育委员会. WS/T 557-2017慢性肾脏病患者膳食指导[Z]. 2017-08-01.
[7] Jha, V., Garcia, G., Iseki, K., et al. (2013) Chronic Kidney Disease: Global Dimension and Perspectives. The Lancet, 382, 260-272.
[Google Scholar] [CrossRef] 
[8] 王尊松, 崔美玉, 唐利军, 等. 尿毒症患者肠道菌群变化的研究[J]. 中华肾脏病杂志, 2014, 30(3): 172-176.
[9] Martins, F.S., Silva, A.A., Vieira, A.T., et al. (2009) Comparative Study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii Probiotic Properties. Archives of Microbiology, 191, 623-630.
[Google Scholar] [CrossRef] [PubMed]
[10] Goto, S., Yoshiya, K., Kita, T., et al. (2011) Uremic Toxins and Oral Adsorbents. Therapeutic Apheresis and Dialysis, 15, 132-134.
[Google Scholar] [CrossRef] [PubMed]
[11] Kotanko, P., Carter, M. and Levin, N.W. (2006) Intestinal Bacterial Microflora a Potential Source of Chronic Inflammation in Patients with Chronic Kidney Disease. Nephrology Dialysis Transplantation, 21, 2057-2060.
[Google Scholar] [CrossRef] [PubMed]
[12] Lin, C.J., Liu, H.L., Pan, C.F., et al. (2012) Indoxyl Sulfate Predicts Cardio Vascular Disease and Renal Function Deterioration in Advanced Chronic Kidney Disease. Archives of Medical Research, 43, 451-456.
[Google Scholar] [CrossRef] [PubMed]
[13] Shimizu, H., Bolali, D., Adiang, A., et al. (2011) NF-κB Plays an Important Role in Indoxyl Sulfate-Induced Cellular Senescence, Fibrotic Gene Expression, and Inhibition of Proliferation in Proximal Tubular Cells. American Journal of Physiology-Cell Physiology, 301, c1201-c1212.
[Google Scholar] [CrossRef] [PubMed]
[14] Niwa, T. (2010) Indoxyl Sulfate Is a Nephm-Vascular Toxin. Journal of Renal Nutrition, 20, S2-S6.
[Google Scholar] [CrossRef] [PubMed]
[15] Niwa, T. and Shimizu, H. (2012) Indoxyl Sulfate Induces Nephrovascular Senescence. Journal of Renal Nutrition, 22, 102-106.
[Google Scholar] [CrossRef] [PubMed]
[16] Sabatino, A., Regolisti, G., Brusasco, I., et al. (2015) Alterations of Intestinal Barrier and Microbiota in Chronic Kidney Disease. Nephrology Dialysis Transplantation, 30, 924-933.
[Google Scholar] [CrossRef] [PubMed]
[17] 张镭, 聂静. 肠道菌群与慢性肾脏病[J]. 临床肾脏病杂志, 2016, 16(11): 697-700.
[18] Vaziri, N.D., Wong, J., Pahl, M., et al. (2013) Chronic Kidney Disease Alters Intestinal Microbial Flora. Kidney International, 83, 308-315.
[Google Scholar] [CrossRef] [PubMed]
[19] Nallu, A., Sharma, S., Ramezani, A., et al. (2017) Gut Microbiome in Chronic Kidney Disease: Challenges and Opportunities. Translational Research, 179, 24-37.
[Google Scholar] [CrossRef] [PubMed]

为你推荐